On September 22, Caris Life Sciences, Inc. rose 5.38% in regular trading, trading at $32.22 USD/share, with Turnover of $34.05 million.

Within the Biotechnology sector where Caris Life Sciences, Inc. belongs, the overall sector showed broad strength. Among individual stocks, Viking Therapeutics up 30.32%, Moderna, Inc. up 3.71%, Decoy Therapeutics Inc up 157.42%, Greenland Mines up 39.38%, Amgen up 1.39%.

Caris Life Sciences, Inc. is a leading patient-centered next-generation artificial intelligence technology biology company and precision medicine pioneer. It develops and commercializes innovative solutions to transform health care through the large-scale use of comprehensive molecular information and AI/ML algorithms, with an initial focus on oncology and serving the clinical, academic and biopharmaceutical markets.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)